Document Type : Original Article

Authors

1 Department of Biology, Faculty of Engineering and Science, Yazd University of Science and Art, Yazd, Iran

2 Department of Biology, Payame Noor University, Yazd, Iran

10.22034/ijabbr.2021.526486.1355

Abstract

Background: Ovarian cancer is one of the most common malignancies among women worldwide and is also the fifth leading cause of cancer death among women in recent years. Herbs have been used for centuries to treat a variety of ailments, including cancers. Medicinal plants can be use d in pure form or in combination with others.
Methods: In this study, after preparing the plant dry, extracts of Artemisia absinthium and Cuscuta epithymum were extracted by Soxhlet method. After Preparation of cell culture medium, Investigations continued. MTT test and Gap closure test were performed to evaluate the toxicity of Cuscuta Epithymum and Artemisia Absinthium Species on CP70 Ovarian Cancer Cells to Compared these two extracts mortality rate.
Results: The lowest cell migration in 48 h was related to A. absinthium treatments with concentrations of 1: 100 and 1: 1000. The lowest cell migration in the period of 72h is related to the treatment of C. epithymum with a concentration of 1: 1000, which these results are less significant than the effect of A. absinthium. The lowest cell migration in the period of 72h is related to the treatment of C. epithymum with a concentration of 1: 1000, which these results are less significant than the effect of A. absinthium.
Conclusions: MTT test showed that the treatment of plant extracts of C. epithymum and A. absinthium can disrupt the growth process as well as the migration and progression of CP70 cancer cells of ovarian cancer and cause cell apoptosis.

Graphical Abstract

The Toxicological effect of Cuscuta epithymum and Artemisia absinthium species on CP70 ovarian cancer cells

Keywords

Main Subjects

1. Rezaeinodehi A, Khangholi S. (2008). Chemical composition of the essential oil of Artemisia absinthium growing wild in Iran. Pak J Biol Sci, 11(6): 946-949.
2. Akbar S. (2020). Artemisia absinthium L.(Asteraceae/Compositae) Handbook of 200 Medicinal Plants (pp. 335-344): Springer.
3. Bami S S, Khavari-Nejad R A, Ahadi A M, Rezayatmand Z. (2021). TiO 2 nanoparticles effects on morphology and physiology of Artemisia absinthium L. under salinity stress. Iranian Journal of Science and Technology, Transactions A: Science, 45(1): 27-40.
4. Nazeri M, Mirzaie-Asl A, Saidijam M, Moradi M. (2020). Methanolic extract of Artemisia absinthium prompts apoptosis, enhancing expression of Bax/Bcl-2 ratio, cell cycle arrest, caspase-3 activation and mitochondrial membrane potential destruction in human colorectal cancer HCT-116 cells. Molecular Biology Reports, 47(11): 8831-8840.
5. Fazeli-Nasab B, Sayyed R Z, Sobhanizadeh A. (2021). In Silico Molecular Docking Analysis of α-Pinene: An Antioxidant and Anticancer Drug Obtained from Myrtus communis. International Journal of Cancer Management, 14(2): e89116. https://doi.org/10.5812/ijcm.89116
6. Buso P, Manfredini S, Reza Ahmadi-Ashtiani H, Sciabica S, Buzzi R, Vertuani S, Baldisserotto A. (2020). Iranian Medicinal Plants: From Ethnomedicine to Actual Studies. Medicina, 56(3): 97.
7. Forouzanfar F, Vahedi M M, Aghaei A, Rakhshandeh H. (2020). Hydroalcoholic Extract of Cuscuta Epithymum Enhances Pentobarbitalinduced Sleep: Possible Involvement of GABAergic System. Current drug discovery technologies, 17(3): 332-337.
8. Sobhanizadeh A, Solouki M, Fazeli-Nasab B. (2017). Optimization of callus induction and effects of biological and non-biological elicitors on content of phenol/flavonoid compounds in Nigella sativa under in-vitro conditions. Journal of Cell & Tissue, 8(2): 165-184. https://doi.org/10.29252/JCT.8.2.165
9. Fazeli-nasab B, Moshtaghi N, Forouzandeh M. (2019). Effect of Solvent Extraction on Phenol, Flavonoids and Antioxidant Activity of some Iranian Native Herbs. Scientific Journal of Ilam University of Medical Sciences, 27(3): 14-26 https:doi.org/10.29252/sjimu.27.3.14
10. Konstantinopoulos P A, Norquist B, Lacchetti C, Armstrong D, Grisham R N, Goodfellow P J, Kohn E C, Levine D A, Liu J F, Lu K H. (2020). GermLine and somatic tumor testing in epithelial ovarian cancer: ASCO guideline. Journal of Clinical Oncology, 38(11): 1222-1245.
11. Rezaei-Nasab M, Komeili G, Fazeli-Nasab B. (2017). Gastroprotective effects of aqueous and hydroalcholic extract of Scrophularia striata on ethanol-induced gastric ulcers in rats. Der Pharmacia Lettre, 9(5): 84-93.
12. Matulonis U A, Sood A K, Fallowfield L, Howitt B E, Sehouli J, Karlan B Y. (2016). Ovarian cancer. Nature Reviews Disease Primers, 2(1): 1-22.
13. Izar B, Tirosh I, Stover E H, Wakiro I, Cuoco M S, Alter I, Rodman C, Leeson R, Su M-J, Shah P. (2020). A single-cell landscape of high-grade serous ovarian cancer. Nature medicine, 26(8): 1271-1279.
14. Jiang Y, Wang C, Zhou S. (2020). Targeting tumor microenvironment in ovarian cancer: premise and promise. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1873(2): 188361.
15. Zhang H, Hu L, Cheng M, Wang Q, Hu X, Chen Q. (2020). The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer. Oncology reports, 44(6): 2610-2620.
16. Garcia N, Ulin M, Al-Hendy A, Yang Q. (2020). The Role of Hedgehog Pathway in Female Cancers. Journal of cancer science and clinical therapeutics, 4(4): 487.
17. Lee H, Kim J W, Choi D K, Yu J H, Kim J H, Lee D-S, Min S-H. (2020). Poziotinib suppresses ovarian cancer stem cell growth via inhibition of HER4-mediated STAT5 pathway. Biochemical and biophysical research communications, 526(1): 158-164.
18. Lengyel E. (2010). Ovarian cancer development and metastasis. The American journal of pathology, 177(3): 1053-1064.
19. Danlami J M, Arsad A, Zaini M A A. (2015). Characterization and process optimization of castor oil (Ricinus communis L.) extracted by the soxhlet method using polar and non-polar solvents. Journal of the Taiwan Institute of Chemical Engineers, 47: 99-104.
20. Gu L-B, Zhang G-J, Du L, Du J, Qi K, Zhu X-L, Zhang X-Y, Jiang Z-H. (2019). Comparative study on the extraction of Xanthoceras sorbifolia Bunge (yellow horn) seed oil using subcritical n-butane, supercritical CO2, and the Soxhlet method. Lwt, 111: 548-554.
21. Ebe K, Hashimoto M, Bando H, Bando M, Mayorga B, Muneta T. (2020). Proposal of Meal Tolerance Test (MTT) For Investigating Ability of Insulin Secretion for Small Carbohydrate Load. Diabetes Research: Open Access, 2020(2): 31.
22. Wei Q, Shi X, Zhao T, Cai P, Chen T, Zhang Y, Huang C, Yang J, Chen X, Zhang S. (2020). Actin-ring segment switching drives nonadhesive gap closure. Proceedings of the National Academy of Sciences, 117(52): 33263-33271.
23. Shafi G, Hasan T N, Syed N A, Al-Hazzani A A, Alshatwi A A, Jyothi A, Munshi A. (2012). Artemisia absinthium (AA): a novel potential complementary and alternative medicine for breast cancer. Mol Biol Rep, 39(7): 7373-7379. 10.1007/s11033-012-1569-0
24. Noureen S, Noreen S, Ghumman S A, Batool F, Bukhari S N A. (2019). The genus Cuscuta (Convolvolaceac): An updated review on indigenous uses, phytochemistry, and pharmacology. Iranian journal of basic medical sciences, 22(11): 1225-1252. 10.22038/ijbms.2019.35296.8407
25. Akbar S. (2020). Cuscuta chinensis Lam.(or C. epithymum L.)(Convovulaceae) Handbook of 200 Medicinal Plants (pp. 817-823): Springer.
26. Taleghani B K, Ghaderi B, Rostampour M, Fekjur E M, Hasannejad F, Ansar M M. (2021). Involvement of opioidergic and GABAergic systems in the anti-nociceptive activity of the methanolic extract of Cuscuta Epithymum Murr. in mice. Journal of Ethnopharmacology, 273: 113826.
27. Batiha G E-S, Olatunde A, El-MLeeh A, Hetta H F, Al-Rejaie S, Alghamdi S, Zahoor M, Magdy Beshbishy A, Murata T, Zaragoza-Bastida A. (2020). Bioactive compounds, pharmacological actions, and pharmacokinetics of wormwood (Artemisia absinthium). Antibiotics, 9(6): 353.
28. Costa C D M, Boaretto A, da Silva S S, Nepomuceno S C, Silva D B, Alves F M. (2020). New records of Cuscuta L.(Convolvulaceae) in Central-West Brazil. Check List, 16: 1725.
29. Fronza G, Monti P, Menichini P, Speciale A, Cutrona G, Fais F, Taiana E, Neri A, Bomben R, Gentile M. (2020). Heterogeneity of TP53 mutations and P53 protein residual function in cancer: does it matter? Frontiers in Oncology, 10: 2313.
30. Betancur-Galvis L, Saez J, Granados H, Salazar A, Ossa J. (1999). Antitumor and antiviral activity of Colombian medicinal plant extracts. Mem Inst Oswaldo Cruz, 94(4): 531-535. 10.1590/s0074-02761999000400019
31. Rhode J, Fogoros S, Zick S, Wahl H, Griffith K A, Huang J, Liu J R. (2007). Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC complementary and alternative medicine, 7: 44-44. 10.1186/1472-6882-7-44
32. Mansour D F, Abdallah H M I, Ibrahim B M M, Hegazy R R, Esmail R S E, Abdel-Salam L O. (2019). The Carcinogenic Agent Diethylnitrosamine Induces Early Oxidative Stress, Inflammation and Proliferation in Rat Liver, Stomach and Colon: Protective Effect of Ginger Extract. Asian Pacific journal of cancer prevention : APJCP, 20(8): 2551-2561. 10.31557/APJCP.2019.20.8.2551